News London cab drivers’ brains to be studied for Alzheimer’s research Asher Notheis · November 1, 2021 3:56 pm
Healthcare FDA panel criticizes agency approval of controversial $56,000 Alzheimer’s drug David Hogberg · July 28, 2021 9:33 pm
Healthcare Prescription drug ‘sticker prices’ may rise in 2021 after years of decline David Hogberg · July 21, 2021 11:00 am
Healthcare The group Public Citizen wants FDA chief Janet Woodcock removed from her post Cassidy Morrison · July 16, 2021 3:00 am
Healthcare FDA head invites investigation into agency contact with manufacturer of controversial Alzheimer’s treatment Cassidy Morrison · July 9, 2021 8:09 pm
Healthcare FDA narrows eligibility for controversial $56,000 Alzheimer’s treatment Cassidy Morrison · July 8, 2021 7:14 pm
Healthcare In cost-saving move, Medicare could limit patient access to Alzheimer’s treatment Cassidy Morrison · June 29, 2021 10:30 am
Healthcare Controversial Alzheimer’s drug a godsend for a trial participant, but price tag could put it out of reach Cassidy Morrison · June 25, 2021 3:00 am
Healthcare Liberal watchdog group pushes FDA leadership to resign over controversial Alzheimer’s treatment approval Cassidy Morrison · June 17, 2021 3:36 pm
Healthcare Approval of controversial $56,000 Alzheimer’s treatment could add $57 billion to federal spending Cassidy Morrison · June 16, 2021 10:29 am
Healthcare Three members of FDA drug review panel resign over approval of $56K Alzheimer’s drug Cassidy Morrison · June 11, 2021 2:59 pm
Healthcare Scientists discover potentially dangerous metals in brains of Alzheimer’s patients David Hogberg · June 10, 2021 2:47 pm